Celyad Highlights Abstracts from mCRC Clinical Program Released for SITC 34th Annual Meeting

Celyad is a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T cell-based product candidates and utilizes its expertise in cell engineering to target cancer.